caris life science

Irving’s Caris Life Sciences Closes On $400M Secured Term Loan

by | Jan 23, 2023

Caris Life Sciences, the Irving-based biotech company, announced Thursday that it closed a senior secured term loan providing up to $400 million in capital from OrbiMed and Braidwell, bringing its funding total since 2018 to roughly $1.7 billion.

Caris, a molecular science and technology company that is actively developing and delivering innovative solutions to revolutionize healthcare, said it will use the proceeds to repay debt, improve its unique precision medicine platform, and for general corporate purposes....

MORE
Irving’s Caris Life Sciences Raises $830M to Grow Its Precision Medicine Platform for Cancer Care
by | May 12, 2021
Now valued at more than $7.8 billion, Caris specializes in AI-powered genetic sequencing for personalized cancer treatments. The massive capital raise follows a $310 million round in October and boosts the 13-year-old company's total funding to about $1.3 billion.
MORE